Our News on Newswise

Reverse-order heart-liver transplant helps prevent rejection for highly sensitized patients

Patients with high levels of antibodies face major challenges getting a transplant. These highly sensitized patients have a higher risk of death while waiting for suitable organs. But there is new hope for highly sensitized patients in need of a...
1-Apr-2021 11:55 AM EDT Add to Favorites

与神经退行性疾病相似的遗传性心脏病的细胞途径

针对一种遗传性心脏病的研究发现了一种意想不到的心力衰竭新机制。这一里程碑式的发现在RNA结合蛋白(长期以来被认为与神经退行性疾病有关)的聚集与RBM20扩张型心肌病患者心脏组织...
25-Mar-2021 5:40 PM EDT Add to Favorites

الطب الدقيق، والتكنولوجيا الرقمية لديهما إمكانات كأدوات قوية ضد داء السل

تكتسب المعركة العالمية ضد داء السل بعض الأدوات القوية. الطب الدقيق — المُستخدم بالفعل لتخصيص تشخيص الأمراض غير المعدية وعلاجها، مثل:...
25-Mar-2021 8:50 AM EDT Add to Favorites

A medicina de precisão e a tecnologia digital apresentam potencial como ferramentas poderosas contra a tuberculose

A luta global contra a tuberculose está ganhando algumas ferramentas poderosas. A medicina de precisão — já usada para personalizar o diagnóstico e o tratamento de doenças não transmissíveis, como o câncer — e as tecnologias de saúde,...
23-Mar-2021 5:00 PM EDT Add to Favorites

精准医学和数字技术有潜力作为抗击肺结核的强大工具

全球抗击肺结核的努力获得了医疗技术的强大助力。精准医学已经用于非传染性疾病(例如癌症)的诊断和治疗,它和远程医学等医疗技术有可能促进结核病的预防和治疗,妙佑医疗国际...
23-Mar-2021 4:55 PM EDT Add to Favorites

信使RNA COVID-19疫苗大幅降低无症状COVID-19感染和传播给他人的风险

接受第二剂信使RNA或mRNA COVID-19疫苗10天后,与未接种COVID-19疫苗的患者相比,无症状COVID-19感染者检测为阳性和在不知不觉中传播COVID-19的可能性大幅降低。Pfizer-BioNTech和Moderna信使RNA...
23-Mar-2021 8:15 AM EDT Add to Favorites

As vacinas para COVID-19 de RNA mensageiro reduzem muito o risco de infecção assintomática por COVID-19 disseminada para outras pessoas

Dez dias após receber uma segunda dose de uma vacina para COVID-19 de RNA mensageiro, ou mRNA, pacientes sem sintomas de COVID-19 têm muito menos probabilidade de apresentar teste positivo e espalhar COVID-19 inadvertidamente, em comparação com...
23-Mar-2021 8:15 AM EDT Add to Favorites

لقاحات الحمض النووي الريبوزي المرسال لفيروس كورونا المستجد (كوفيد-19) تُقلل بشكل كبير من خطر انتشار فيروس كورونا المستجد (كوفيد-19) عديم الأعراض للآخرين

بعد عشرة أيام من تلقي الجرعة الثانية من لقاح الحمض النووي الريبوزي المرسال، أو ما يُسمى بـ mRNA لفيروس كورونا المستجد (كوفيد-19)، فإن المرضى...
23-Mar-2021 8:10 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Alerta dos Especialistas: Conhecer o risco de doença renal crônica é ainda mais necessário devido à pandemia de COVID-19

Estima-se que uma a cada dez pessoas ao redor do mundo tem doença renal crônica, mas a maioria delas não sabe disso. A falta de conhecimento é particularmente preocupante porque as pessoas com doença renal crônica que se infectarem com...
10-Mar-2021 5:30 PM EST

تنبيه الخبراء: أهمية الوقاية من أمراض الكلى المزمنة وفحص وجودها

قد لا يشعر الأشخاص المصابون بأمراض الكلى المزمنة بالمرض أو يلاحظون الأعراض. لكنها مصدر قلق صحي عالمي، مع عدد وفيات يُقدَّر بنحو 1.1 مليون...
10-Mar-2021 2:50 PM EST

Saber si hay riesgo de insuficiencia renal crónica es aún más importante debido a pandemia de COVID-19

Se calcula que 1 de cada 10 personas en el mundo sufre de insuficiencia renal crónica, pero la mayoría de ellas no lo saben. Ese desconocimiento es particularmente preocupante porque cuando alguien con insuficiencia renal crónica se infecta con...
10-Mar-2021 2:15 PM EST

Risk for chronic kidney disease even more critical due to COVID-19 pandemic

An estimated 1 in 10 people worldwide have chronic kidney disease, but most of them don't know it. That lack of awareness is especially concerning because people with Chronic kidney disease who are infected with COVID-19 are at higher risk for...
8-Mar-2021 12:05 PM EST

Advertencia del experto: prevenir una encefalitis es otra razón para vacunarse contra la COVID-19

Los pacientes con COVID-19 corren riesgo de presentar complicaciones neurológicas, incluida una encefalitis o inflamación del cerebro.
22-Feb-2021 3:05 PM EST

Expert Alert: Encephalitis prevention another reason to receive COVID-19 vaccine

Patients with COVID-19 are at risk for neurologic complications, including encephalitis, or inflammation of the brain. "Encephalitis cases have been reported in patients with COVID-19, although on the whole it appears to be a relatively rare...
22-Feb-2021 12:30 PM EST

Aviso de un experto: Lo que se avista en el horizonte del mieloma múltiple y otros tipos de cáncer de la sangre

El 4 de febrero de 2021 es el Día Mundial contra el Cáncer y sirve para resaltar cómo podemos todos ayudar a reducir el peso mundial del cáncer. En el año 2018, hubo 17 millones de casos nuevos de cáncer y 9,5 millones de muertes por cáncer...
25-Jan-2021 8:05 AM EST

Expert alert: Changing the outlook for pancreatic cancer

Pancreatic cancer often is hidden and doesn't cause symptoms until it has spread. It is a leading cause of cancer deaths in the world. November 19 is World Pancreatic Cancer Day, but the entire month of November is meant to bring awareness to...
11-Nov-2020 1:45 PM EST

See All Experts

Our YouTube Videos

About

The mission of Mayo Clinic is to inspire hope and contribute to health and well-being by providing the best care to every patient through integrated clinical practice, education and research.

Experts

Contacts

Emily Blahnik
Media Relations Coordinator

blahnik.emily@mayo.edu

507-538-7404

Vicki Chambard Torkelson
Media Relations Coordinator

ChambardTorkelson.Vicki@mayo.edu

Lynn Closway
Public Affairs Specialist

closway.lynn@mayo.edu

480-301-4337

Joe Dangor
Public Affairs
Health, Medical Research

dangor.yusuf@mayo.edu

507-266-0696

Emily DeBoom
Media Relations Coordinator

deboom.emily@mayo.edu

507-293-1536

Julie Denouden
Karl's Assistant

denouden.julie@mayo.edu

507-293-3965

Kelley Luckstein
Senior Communications Specialist, Public Affairs

luckstein.kelley@mayo.edu

507-538-5554

Terri Malloy
Public Affairs Specialist

malloy.teresa@mayo.edu

507-250-6010

Terri Malloy
Senior Public Affairs Specialist

malloy.teresa@mayo.edu

Jim McVeigh
Public Affairs

mcveigh.jim@mayo.edu

480-301-4368

Bob Nellis
Research Communications Consultant

nellis.robert@mayo.edu

507-284-9521

Karl Oestreich
Director, Media Relations

Oestreich.karl@mayo.edu

507-293-0967

Ginger Plumbo
Communications Consultant

Plumbo.Ginger@mayo.edu

507-266-0517

Kevin Punsky

punsky.kevin@mayo.edu

904-953-0746

Melissa Repanshek
Administrative Assistant

repanshek.melissa@mayo.edu

904-953-7339

Sharon Theimer
Mayo Clinic Media Relations
public affairs

newsbureau@mayo.edu

507-284-5005

Joan Turner

turner.joan@mayo.edu

480-301-4232

Mayo Clinic raises awareness about organ donation during National Donate Life Month

ROCHESTER, Minn. — More than 107,000 people in the U.S. are on the waiting list for an organ transplant. Sad...
12 Apr 2021

Study of mouse gut microbiome may provide clues to how cancer develops in humans

ROCHESTER, Minn. ― A study of the mouse gut microbiome led by researchers from Mayo Clinic may shed light o...
09 Apr 2021

Reverse-order heart-liver transplant helps prevent rejection for highly sensitized patients

ROCHESTER, Minn. — All too often, patients with high levels of antibodies face major challenges getting a tr...
01 Apr 2021

Mayo Clinic and ASU MedTech Accelerator boosts health startups

The MedTech Accelerator is a flagship program of Mayo Clinic and Arizona State University Alliance for Health ...
30 Mar 2021

Mayo Clinic, Thermo Fisher Scientific collaborate to benefit patients

ROCHESTER, Minn. ― Mayo Clinic and Thermo Fisher Scientific have joined forces to bring innovative solutions...
25 Mar 2021

Expert alert: 5 tips for getting back into the game

ROCHESTER, Minn – People look forward to opening day of baseball season, perhaps even more this year amid th...
23 Mar 2021

Expert Alert: Precision medicine, digital technology hold potential as powerful tools against tuberculosis

World Tuberculosis Day is March 24 ROCHESTER, Minn. —  The global fight against tuberculosis is gaining...
22 Mar 2021

Lack of diversity in genomic databases may affect therapy selection for minority groups

ROCHESTER, Minn. — Low representation of minority groups in public genomic databases may affect therapy sele...
19 Mar 2021

Genetic testing proves beneficial in prescribing effective blood thinners

ROCHESTER, Minn. — Pharmacogenomics is a valuable tool for health care providers to help prescribe the right...
17 Mar 2021

$60 million gift to Mayo Clinic will accelerate efforts to transform health care delivery in Minnesota

ROCHESTER, Minn. — A generous gift of $60 million from philanthropist Helene Houle of St. Paul, Minnesota, w...
15 Mar 2021

Twitter

close
5.94599